0
2022
Dermatologicals Market

Dermatologicals Market

by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, and Others), Type (Prescription-based Drugs, and Over-the-Counter Drugs), and Route of Administration (Topical Administration, Oral Administration, and Parenteral Administration): Global Opportunity Analysis and Industry Forecast, 2021--2030

Report Code: A03463
Pages: 262
Jan 2022 | 19461 Views
Author(s) : Linu Dash , Onkar Sumant
Tables: 128
Charts: 51
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Dermatologicals Market

Request Now !

Dermatologicals Market Insights – 2030

The global dermatologicals market size was valued at $19,974.3 million in 2020, and is projected to reach $59,309.3 million by 2030, registering a CAGR of 11.5% from 2021 to 2030. Dermatology is defined as the branch of medicine, which deals with skin and various diseases of skin such as acne, atopic dermatitis, skin cancer, and psoriasis. A dermatologist is a physician having specialization in condition involving hair, skin, and nails. According to the American Academy of Dermatology Association, it was reported that a dermatologist can identify and treat around 3,000 skin-related disease. The skin acts as a barrier of body to protect the internal organ from bacterial and injury. The dermatologic conditions are common, and almost every individual experiences symptoms of one or other dermatologic condition at some point in life. 

The growth of the global dermatologicals market is majorly driven by increase in prevalence of skin diseases such as acne, atopic dermatitis, skin cancer, and rosacea; rise in demand for topical dermatological products; increase in funding from private & government organizations for development of pharmaceutical manufacturing segments; and rise in R&D activities for advancement of dermatological products. According to the American Cancer Society, in 2021, it was reported that around 106,110 new melanoma cases are diagnosed in U.S. In addition, according to American Academy of Dermatology, in 2021, it reported that skin cancer is the most common cancer in the U.S.

Dermatologicals-Market

Furthermore, increase in number of approval for dermatological products drives growth of the market. For instance, in December 2021, AbbVie Inc., a pharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for Rinvoq (upadacitinib) for the treatment of patient suffering from active psoriatic arthritis. This drug is recommended for the patient who had intolerance or inadequate response to the tumor necrosis factor blockers. 

In addition, increase in number of clinical studies for evaluating safety and efficiency of a wide range of therapeutic drugs is anticipated to contribute toward growth of the dermatologicals market. For instance, in December 2021, Amgen Inc., a pharmaceutical company, announced the positive result from phase 3 placebo controlled, double blind clinical study. The study aims to analyze the efficiency of Otezla for treatment of moderate to severe psoriasis. The study reported that Otezla (oral 30 mg) resulted in significantly improvement in the symptoms of genital psoriasis at 16 week as compared to placebo group.  Moreover, increase in prevalence of teenager and younger population, who are more susceptible to skin diseases, due to hormonal change propel growth of the market. According to the American Academy of Dermatology, it was observed that around 85% of population between the age of 12 to 24 years is affected with minor acne. 

Furthermore, technological development in the pharmaceutical industry to manufacture advanced dermatological products is expected to provide remunerative opportunities for expansion of the global dermatologicals market during the forecast period. Moreover, presence of key manufacturing companies to manufacture and distribute dermatologicals products and rise in expenditure on healthcare products propel growth of the dermatologicals market.

Initiatives taken by government and private organizations to develop pharmaceutical industry propel the growth of the market. However, the presence of alternative for acne treatment such as light or lasers therapies, chemical peels, micro needling, micro dermabrasion, and lesion removal is expected to restrict the dermatologicals market growth during the forecast period.

Global Dermatologicals Market Segmentation

The global dermatologicals market is segmented into disease, type, route of administration, and region. By disease, the market is categorized into acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and others. 

On the basis of type, it is divided into prescription-based drugs, and over-the-counter drugs. Depending on route of administration, it is categorized into topical administration, oral administration, and parenteral administration.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Saudi Arabia, the UAE, Russia, Kazakhstan, Azerbaijan, Iran, Algeria, Egypt, and rest of LAMEA).

Dermatologicals Market
By Disease

Your browser does not support the canvas element.

Psoriasis segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment review

Depending on disease, the acne capsules segment dominated the dermatologicals market in 2020, and this trend is expected to continue during the forecast period, owing to advancements in R&D activities in the healthcare sector and increase in prevalence of acne.

However, the dermatitis segment is expected to witness considerable growth during the forecast period, owing to increase in demand for dermatitis.

Dermatologicals Market
By Type

Your browser does not support the canvas element.

Prescription-Based Drugs segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By type, the prescription-based drugs segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of skin diseases and initiatives taken by government and private organization about skin disease. However, the over-the-counter drugs segment is expected to witness considerable growth during the forecast period, owing to increase in demand for over-the-counter drugs and increase in number of approval for over-the-counter drugs.

On the basis of route of administration, the topical administration segment dominated the dermatologicals market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for topical administration, rise in number of U.S. FDA approval for drug, and advancements in R&D activities in pharmaceutical sectors. However, the parenteral administration segment is expected to witness considerable growth during the forecast period, owing to advancement in technology in the healthcare sector and rise in number of biologics drugs.

Dermatologicals Market
By Administration

Your browser does not support the canvas element.

Topical Administration segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America garnered a major share in the dermatologicals market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of acne, increase in number of approval for dermatological products, presence of key players, and development in R&D activities in healthcare sector in the region. However, Asia-Pacific is expected to register highest CAGR of 12.3% from 2021 to 2030, owing to increase in prevalence of skin disease, rise in awareness about the use of dermatological drugs, growth in health care expenditures, and rise in adoption of aesthetic product. 

The key players operating in the global dermatologicals market include AbbVie Inc. (Allergan PLC)., Amgen Inc., Galderma, GlaxoSmithKline Plc., Johnson & Johnson Services Inc, Leo Pharma A/S, Novartis AG, Organon & Co (Merck), Pfizer Inc., and Sun Pharmaceutical Industries Limited. 

Dermatologicals Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the dermatologicals market, and the current trends &future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing dermatologicals market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the dermatologicals industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Dermatologicals Market Report Highlights

Aspects Details
By Key Market Players
  • AbbVie Inc. (Allergan PLC).
  • Amgen Inc.
  • Galderma
  • GlaxoSmithKline Plc.
  • Johnson & Johnson Services Inc
  • Leo Pharma A/S
  • Novartis AG
  • Organon & Co (Merck)
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited.
By Disease
  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Rosacea
  • Alopecia
  • Others
By Type
  • Prescription-based drugs
  • Over-the-counter drugs
By Route of Administration
  • Topical Administration
  • Oral Administration
  • Parenteral Administration
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
 

Loading Table Of Content...


 
 

This section provides the opinions of the top-level CXOs operating in the global dermatologicals market. According to the insights of the CXOs, the global dermatologicals market is expected to exhibit high growth potential attributable to factors such as rise in in R&D activities in pharmaceutical industry for manufacturing of dermatologicals; increase in prevalence of skin diseases, such as acne, atopic dermatitis, rosacea; and surge in number of approvals by the U.S. Food and Drug Administration (FDA) for dermatologicals. Furthermore, the dermatologicals market has gained interest of pharmaceutical manufacturing companies, owing to surge in demand for skin care products and dermatological drugs. Moreover, increase in number of teenagers, who are highly prone to skin diseases, due to change in hormonal level, notably contributes toward the growth of the market.

The CXOs further added that North America is expected to witness the highest growth, in terms of revenue, owing to rise in prevalence of acne, increase in number of approvals for dermatological products, and strong presence of key players.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of dermatologicals market is $19,974.3 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of dermatologicals Market in 2021 was $22,331.2 million

A. The base year for the report is 2020.

A. Yes, dermatologicals companies are profiled in the report

A. The top companies that hold the market share in dermatologicals market are are AbbVie Inc. (Allergan PLC)., Amgen Inc., Galderma, GlaxoSmithKline Plc., Johnson & Johnson Services Inc, Leo Pharma A/S, Novartis AG, Organon & Co (Merck), Pfizer Inc., and Sun Pharmaceutical Industries Limited

A. Asia-Pacific is expected to register highest CAGR of 12.3% from 2021 to 2030, owing to increase in prevalence of skin diseases, rise in awareness about the use of dermatological drugs, surge in healthcare expenditure, and increase in adoption of aesthetic products

A. The key trends in the dermatologicals market are by rise in demand for topical dermatological drugs, advancements in R&D activities in the pharmaceutical industry, and surge in demand for skincare products.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Dermatologicals Market

Start reading instantly.
This Report and over 18,752+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jan 2023 - Jan 2024)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2023 - Jan 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2023 - Jan 2024)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2023 - Jan 2024)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2023 - Jan 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers